Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nucor Corporation (NUE) vs Tempus AI (TEM) Price & Performance

Nucor CorporationTrade

Price performance (Past 24H)

Key statistics

Nucor Corporation vs Tempus AI — how do they compare? Nucor Corporation trades at $272.98 (market cap $62.54B), while Tempus AI trades at $55.49 (market cap $9.93B). The key difference: Nucor Corporation is far larger — about 6.3× Tempus AI's market cap, and Nucor Corporation pays a 0.82% dividend while Tempus AI pays none. Which is the better fit depends on your goals.

NUETEM
Market Cap
$62.54B$9.93B
Sector
Basic MaterialsBroad Market / Factor
52-Week High
$274.74$103.25
52-Week Low
$131.78$41.55
Enterprise Value
$66.95B$10.56B
Dividend Yield
0.82%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nucor Corporation

Nucor (NUE) trades at $272.63, up 0.23% on the day, with a bullish technical outlook supported by moving averages and strong resistance near $280. Recent Q2 2026 earnings beat expectations with EPS of $4.84 versus $4.46, driven by record steel shipments and higher prices. Revenue trends show recovery from 2024 lows, with 2026 projections at $36.1B. The stock is near its consensus price target of $279.63, with analyst sentiment leaning bullish (59% buy ratings).

Outlook: Nucor benefits from resilient steel demand and operational efficiency, but faces risks from tariff policies and cyclical industry pressures. The current P/E of 21.76 is reasonable given earnings growth, though net margins have compressed from 2022 peaks. Investors should monitor Q3 2026 results against the $5.72 EPS estimate for continued momentum.

Tempus AI

Tempus AI (TEM) trades at $52.05, up 12.86% in 24 hours, reflecting strong momentum after Q2 2026 earnings beat revenue estimates and raised 2026 sales guidance. The stock is technically bullish with moving averages supporting upside, while fundamentals show revenue growth to $1.4 billion in 2026 but persistent net losses. Recent news highlights expansion through the Personalis acquisition and AI-driven precision medicine advancements.

Outlook: Growth prospects are robust with AI adoption in healthcare and strategic deals, but high valuation ratios and negative profitability pose risks. Analysts are bullish with a $61.57 consensus target, though cash burn and competitive pressures require monitoring for sustained investor confidence.

Returns comparison

Trailing returns across standard periods

About Nucor Corporation

Nucor Corp manufactures steel and steel products. The company also produces direct reduced iron for use in its steel mills. The operations include international trading and sales companies that buy and sell steel and steel products manufactured by the company and others. The operating business segments are: steel mills, steel products and raw materials, the steel mills segment derives maximum revenue.

Read more on NUE

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Read more on TEM